0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Transdermal Patch Market Size, Share, Manufacturers, Industry Analysis, Supply Chain, Sales Channel and Clients, Forecast 2022-2028
Published Date: August 2021
|
Report Code: QYRE-Auto-M8
Home | Market Reports | Health| Pharmacy
Global Transdermal Patch Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Transdermal Patch Market Size, Share, Manufacturers, Industry Analysis, Supply Chain, Sales Channel and Clients, Forecast 2022-2028

Code: QYRE-Auto-M8
Report
August 2021
119 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Transdermal Patch market Analysis 2022-2028

Due to the COVID-19 pandemic, the global Transdermal Patch market size is estimated to be worth US$ 7058.3 million in 2022 and is forecast to a readjusted size of US$ 8726.9 million by 2028 with a CAGR of 3.6% during the review period.

 Transdermal Patch Market

Fully considering the economic change by this health crisis, Methyl Salicylate-based Patch accounting for % of the Transdermal Patch global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Rx Channel segment is altered to an % CAGR throughout this forecast period.

Key drivers of the transdermal patch market include the growing painless and non-invasive medicinal therapies for chronic diseases such as Parkinson’s, Alzheimer’s, migraine, joint, muscle pain, etc.

The technological developments in drug delivery systems will further propel the transdermal patch market growth in the coming years.

The increasing awareness regarding the harmful effects of tobacco and smoking will accelerate the market expansion during the review period.

However, Skin irritation, infection and permeability concerns will restrict the market in the upcoming years. The inability of the skin to absorb a large number of medications is expected to create hurdles moving ahead.

What is Transdermal Patch?

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Trends Influencing the Transdermal Patch Market

The growing popularity of self-administered non-invasive therapies

Transdermal patches are gaining widespread acceptance over oral medications. The benefits include smooth and faster drug delivery through non-invasive means. The easy availability, visual cue, hassle-free administration, and limited drug interaction boost its widescale usage in the medical industry, especially amongst the geriatric population. Moreover, methyl salicylate-based patches make the skin feel cool and warm simultaneously distracting the patient from the actual pain of muscle or joints. Hence these patches are being developed for a variety of chronic diseases which in turn will spur the growth of the transdermal patch market in the upcoming years.

Technological innovations

Widespread product innovations have come out in the form of gels, spray, and patches with adhesive layers. Procedures such as thermal ablation, microneedles, and novel systems for drug delivery are being developed. For example, thermal ablation is a system through which skin permeability is achieved in a non-invasive way by removing the stratum corneum or the outermost epidermal layer of the skin. These attractive developments will augment the transdermal patch market growth during the review period.

Anti-smoking population

Smoking is a global healthcare burden. It leads to a variety of diseases such as oral cancer, heart disease, stroke, lung infection, chronic obstructive pulmonary disorder( COPD) and rheumatoid arthritis, etc. Moreover, tobacco kills around 8 million people every year. Hence people are quitting smoking for improving their quality of life. Nicotine-based patches are used for decreasing the withdrawal symptoms caused due to sudden stoppage of cigarette smoking. This will drive the growth of the transdermal patch market in the future.

Skin side effects

Transdermal skin patches are ineffective as skin is a strong barrier to outer elements. The molecules small enough are able to penetrate and mix into the bloodstream of patients. Moreover, there are complications such as skin irritation, infection in the case of people with sensitive skin. Hence these factors will hamper the acceleration of the transdermal patch market in subsequent years.

Transdermal Patches Market Size and Share

Based on type, the methyl salicylate-based patches will grow the highest in the transdermal patch market share with 18% followed by Lidocaine with 15%.

Transdermal Patch Market share

Based on application, the Rx channel will provide lucrative opportunities for growth in the transdermal patch market share with 76% penetration.

Based on region, North America is expected to maintain dominance in the transdermal patch market share due to rapid R&D initiatives and the rising geriatric population who will benefit from the painless administration of medicinal drugs.

Competitive Landscape and Transdermal Patch Market Insights

Transdermal Patch market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Transdermal Patch product introduction, recent developments, Transdermal Patch sales by region, type, application and by sales channel.

Transdermal Patch Market Size

Transdermal Patch Market Segment and Scope

Transdermal Patch market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Transdermal Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Transdermal Patch Market Segment by Type

  • Methyl Salicylate-based Patch
  • Rivastigmine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Nicotine Transdermal Patch
  • Others

Transdermal Patch Market Segment By Application

  • Rx Channel
  • OTC Channel

Regional and Country-level Analysis:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players of Transdermal Patch Market 

  • Hisamitsu Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • UCB Pharma
  • Mylan
  • Teva Pharmaceutical
  • Nitto Denko
  • Grünenthal
  • IBSA Group
  • GSK
  • Luye Pharma Group
  • Pfizer
  • Chattem
  • Dr Reddy’s Laboratories
  • Bayer
  • Mundipharma
  • Endo International
  • Beijing Tide Pharmaceutical

Transdermal Patch Market Report Coverage

Report Metric

Details

Base Year:

2021

Market Size in 2022:

USD 7058.3 Million

Forecast Period:

2022 to 2028

Forecast Period 2021 to 2027 CAGR:

3.6%

2028 Value Projection:

USD  8726.9 Million

No. of Pages:

119

Tables & Figures

164

Segments covered:

Type, Application, Region

Frequently Asked Questions About This Report

1. What would be the forecast period in the Transdermal Patch Market report?

Ans. The forecast period in the Transdermal Patch Market report is from 2022 to 2028.

2. Which Segment is a major contributor to the growth of the Transdermal Patch market?

Ans. Methyl Salicylate-based segment is a major contributor to the growth of the Transdermal Patch market.

3. How big is Transdermal Patch Market?

Ans. The Global Transdermal Patch Market size is projected to reach USD 8726.9 Million by 2028 with a CAGR of 3.6% during the forecast period.

1 Study Coverage

    1.1 Transdermal Patch Product Introduction

    1.2 Market by Type

        1.2.1 Global Transdermal Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

        1.2.2 Methyl Salicylate-based Patch

        1.2.3 Rivastigmine Transdermal Patch

        1.2.4 Fentanyl Transdermal Patch

        1.2.5 Lidocaine Patch

        1.2.6 Diclofenac Patch

        1.2.7 Nicotine Transdermal Patch

        1.2.8 Others

    1.3 Market by Application

        1.3.1 Global Transdermal Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

        1.3.2 Rx Channel

        1.3.3 OTC Channel

    1.4 Study Objectives

    1.5 Years Considered

2 Executive Summary

    2.1 Global Transdermal Patch Sales Estimates and Forecasts 2017-2028

    2.2 Global Transdermal Patch Revenue Estimates and Forecasts 2017-2028

    2.3 Global Transdermal Patch Revenue by Region: 2017 VS 2021 VS 2028

    2.4 Global Transdermal Patch Sales by Region

        2.4.1 Global Transdermal Patch Sales by Region (2017-2022)

        2.4.2 Global Sales Transdermal Patch by Region (2023-2028)

    2.5 Global Transdermal Patch Revenue by Region

        2.5.1 Global Transdermal Patch Revenue by Region (2017-2022)

        2.5.2 Global Transdermal Patch Revenue by Region (2023-2028)

    2.6 North America

    2.7 Europe

    2.8 Asia-Pacific

    2.9 Latin America

    2.10 Middle East & Africa

3 Competition by Manufacturers

    3.1 Global Transdermal Patch Sales by Manufacturers

        3.1.1 Global Top Transdermal Patch Manufacturers by Sales (2017-2022)

        3.1.2 Global Transdermal Patch Sales Market Share by Manufacturers (2017-2022)

        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Transdermal Patch in 2021

    3.2 Global Transdermal Patch Revenue by Manufacturers

        3.2.1 Global Transdermal Patch Revenue by Manufacturers (2017-2022)

        3.2.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2017-2022)

        3.2.3 Global Top 10 and Top 5 Companies by Transdermal Patch Revenue in 2021

    3.3 Global Transdermal Patch Sales Price by Manufacturers (2017-2022)

    3.4 Analysis of Competitive Landscape

        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

        3.4.2 Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

        3.4.3 Global Transdermal Patch Manufacturers Geographical Distribution

    3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

    4.1 Global Transdermal Patch Sales by Type

        4.1.1 Global Transdermal Patch Historical Sales by Type (2017-2022)

        4.1.2 Global Transdermal Patch Forecasted Sales by Type (2023-2028)

        4.1.3 Global Transdermal Patch Sales Market Share by Type (2017-2028)

    4.2 Global Transdermal Patch Revenue by Type

        4.2.1 Global Transdermal Patch Historical Revenue by Type (2017-2022)

        4.2.2 Global Transdermal Patch Forecasted Revenue by Type (2023-2028)

        4.2.3 Global Transdermal Patch Revenue Market Share by Type (2017-2028)

    4.3 Global Transdermal Patch Price by Type

        4.3.1 Global Transdermal Patch Price by Type (2017-2022)

        4.3.2 Global Transdermal Patch Price Forecast by Type (2023-2028)

5 Market Size by Application

    5.1 Global Transdermal Patch Sales by Application

        5.1.1 Global Transdermal Patch Historical Sales by Application (2017-2022)

        5.1.2 Global Transdermal Patch Forecasted Sales by Application (2023-2028)

        5.1.3 Global Transdermal Patch Sales Market Share by Application (2017-2028)

    5.2 Global Transdermal Patch Revenue by Application

        5.2.1 Global Transdermal Patch Historical Revenue by Application (2017-2022)

        5.2.2 Global Transdermal Patch Forecasted Revenue by Application (2023-2028)

        5.2.3 Global Transdermal Patch Revenue Market Share by Application (2017-2028)

    5.3 Global Transdermal Patch Price by Application

        5.3.1 Global Transdermal Patch Price by Application (2017-2022)

        5.3.2 Global Transdermal Patch Price Forecast by Application (2023-2028)

6 North America

    6.1 North America Transdermal Patch Market Size by Type

        6.1.1 North America Transdermal Patch Sales by Type (2017-2028)

        6.1.2 North America Transdermal Patch Revenue by Type (2017-2028)

    6.2 North America Transdermal Patch Market Size by Application

        6.2.1 North America Transdermal Patch Sales by Application (2017-2028)

        6.2.2 North America Transdermal Patch Revenue by Application (2017-2028)

    6.3 North America Transdermal Patch Market Size by Country

        6.3.1 North America Transdermal Patch Sales by Country (2017-2028)

        6.3.2 North America Transdermal Patch Revenue by Country (2017-2028)

        6.3.3 U.S.

        6.3.4 Canada

7 Europe

    7.1 Europe Transdermal Patch Market Size by Type

        7.1.1 Europe Transdermal Patch Sales by Type (2017-2028)

        7.1.2 Europe Transdermal Patch Revenue by Type (2017-2028)

    7.2 Europe Transdermal Patch Market Size by Application

        7.2.1 Europe Transdermal Patch Sales by Application (2017-2028)

        7.2.2 Europe Transdermal Patch Revenue by Application (2017-2028)

    7.3 Europe Transdermal Patch Market Size by Country

        7.3.1 Europe Transdermal Patch Sales by Country (2017-2028)

        7.3.2 Europe Transdermal Patch Revenue by Country (2017-2028)

        7.3.3 Germany

        7.3.4 France

        7.3.5 U.K.

        7.3.6 Italy

        7.3.7 Russia

8 Asia Pacific

    8.1 Asia Pacific Transdermal Patch Market Size by Type

        8.1.1 Asia Pacific Transdermal Patch Sales by Type (2017-2028)

        8.1.2 Asia Pacific Transdermal Patch Revenue by Type (2017-2028)

    8.2 Asia Pacific Transdermal Patch Market Size by Application

        8.2.1 Asia Pacific Transdermal Patch Sales by Application (2017-2028)

        8.2.2 Asia Pacific Transdermal Patch Revenue by Application (2017-2028)

    8.3 Asia Pacific Transdermal Patch Market Size by Region

        8.3.1 Asia Pacific Transdermal Patch Sales by Region (2017-2028)

        8.3.2 Asia Pacific Transdermal Patch Revenue by Region (2017-2028)

        8.3.3 China

        8.3.4 Japan

        8.3.5 South Korea

        8.3.6 India

        8.3.7 Australia

        8.3.8 China Taiwan

        8.3.9 Indonesia

        8.3.10 Thailand

        8.3.11 Malaysia

9 Latin America

    9.1 Latin America Transdermal Patch Market Size by Type

        9.1.1 Latin America Transdermal Patch Sales by Type (2017-2028)

        9.1.2 Latin America Transdermal Patch Revenue by Type (2017-2028)

    9.2 Latin America Transdermal Patch Market Size by Application

        9.2.1 Latin America Transdermal Patch Sales by Application (2017-2028)

        9.2.2 Latin America Transdermal Patch Revenue by Application (2017-2028)

    9.3 Latin America Transdermal Patch Market Size by Country

        9.3.1 Latin America Transdermal Patch Sales by Country (2017-2028)

        9.3.2 Latin America Transdermal Patch Revenue by Country (2017-2028)

        9.3.3 Mexico

        9.3.4 Brazil

        9.3.5 Argentina

10 Middle East and Africa

    10.1 Middle East and Africa Transdermal Patch Market Size by Type

        10.1.1 Middle East and Africa Transdermal Patch Sales by Type (2017-2028)

        10.1.2 Middle East and Africa Transdermal Patch Revenue by Type (2017-2028)

    10.2 Middle East and Africa Transdermal Patch Market Size by Application

        10.2.1 Middle East and Africa Transdermal Patch Sales by Application (2017-2028)

        10.2.2 Middle East and Africa Transdermal Patch Revenue by Application (2017-2028)

    10.3 Middle East and Africa Transdermal Patch Market Size by Country

        10.3.1 Middle East and Africa Transdermal Patch Sales by Country (2017-2028)

        10.3.2 Middle East and Africa Transdermal Patch Revenue by Country (2017-2028)

        10.3.3 Turkey

        10.3.4 Saudi Arabia

11 Company Profiles

    11.1 Hisamitsu Pharmaceutical

        11.1.1 Hisamitsu Pharmaceutical Corporation Information

        11.1.2 Hisamitsu Pharmaceutical Overview

        11.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.1.5 Hisamitsu Pharmaceutical Recent Developments

    11.2 Johnson & Johnson

        11.2.1 Johnson & Johnson Corporation Information

        11.2.2 Johnson & Johnson Overview

        11.2.3 Johnson & Johnson Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.2.4 Johnson & Johnson Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.2.5 Johnson & Johnson Recent Developments

    11.3 Novartis

        11.3.1 Novartis Corporation Information

        11.3.2 Novartis Overview

        11.3.3 Novartis Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.3.4 Novartis Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.3.5 Novartis Recent Developments

    11.4 UCB Pharma

        11.4.1 UCB Pharma Corporation Information

        11.4.2 UCB Pharma Overview

        11.4.3 UCB Pharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.4.4 UCB Pharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.4.5 UCB Pharma Recent Developments

    11.5 Mylan

        11.5.1 Mylan Corporation Information

        11.5.2 Mylan Overview

        11.5.3 Mylan Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.5.4 Mylan Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.5.5 Mylan Recent Developments

    11.6 Teva Pharmaceutical

        11.6.1 Teva Pharmaceutical Corporation Information

        11.6.2 Teva Pharmaceutical Overview

        11.6.3 Teva Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.6.4 Teva Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.6.5 Teva Pharmaceutical Recent Developments

    11.7 Nitto Denko

        11.7.1 Nitto Denko Corporation Information

        11.7.2 Nitto Denko Overview

        11.7.3 Nitto Denko Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.7.4 Nitto Denko Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.7.5 Nitto Denko Recent Developments

    11.8 Grünenthal

        11.8.1 Grünenthal Corporation Information

        11.8.2 Grünenthal Overview

        11.8.3 Grünenthal Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.8.4 Grünenthal Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.8.5 Grünenthal Recent Developments

    11.9 IBSA Group

        11.9.1 IBSA Group Corporation Information

        11.9.2 IBSA Group Overview

        11.9.3 IBSA Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.9.4 IBSA Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.9.5 IBSA Group Recent Developments

    11.10 GSK

        11.10.1 GSK Corporation Information

        11.10.2 GSK Overview

        11.10.3 GSK Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.10.4 GSK Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.10.5 GSK Recent Developments

    11.11 Luye Pharma Group

        11.11.1 Luye Pharma Group Corporation Information

        11.11.2 Luye Pharma Group Overview

        11.11.3 Luye Pharma Group Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.11.4 Luye Pharma Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.11.5 Luye Pharma Group Recent Developments

    11.12 Pfizer

        11.12.1 Pfizer Corporation Information

        11.12.2 Pfizer Overview

        11.12.3 Pfizer Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.12.4 Pfizer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.12.5 Pfizer Recent Developments

    11.13 Chattem

        11.13.1 Chattem Corporation Information

        11.13.2 Chattem Overview

        11.13.3 Chattem Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.13.4 Chattem Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.13.5 Chattem Recent Developments

    11.14 Dr Reddy’s Laboratories

        11.14.1 Dr Reddy’s Laboratories Corporation Information

        11.14.2 Dr Reddy’s Laboratories Overview

        11.14.3 Dr Reddy’s Laboratories Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.14.4 Dr Reddy’s Laboratories Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.14.5 Dr Reddy’s Laboratories Recent Developments

    11.15 Bayer

        11.15.1 Bayer Corporation Information

        11.15.2 Bayer Overview

        11.15.3 Bayer Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.15.4 Bayer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.15.5 Bayer Recent Developments

    11.16 Mundipharma

        11.16.1 Mundipharma Corporation Information

        11.16.2 Mundipharma Overview

        11.16.3 Mundipharma Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.16.4 Mundipharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.16.5 Mundipharma Recent Developments

    11.17 Endo International

        11.17.1 Endo International Corporation Information

        11.17.2 Endo International Overview

        11.17.3 Endo International Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.17.4 Endo International Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.17.5 Endo International Recent Developments

    11.18 Beijing Tide Pharmaceutical

        11.18.1 Beijing Tide Pharmaceutical Corporation Information

        11.18.2 Beijing Tide Pharmaceutical Overview

        11.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales, Price, Revenue and Gross Margin (2017-2022)

        11.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

        11.18.5 Beijing Tide Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

    12.1 Transdermal Patch Industry Chain Analysis

    12.2 Transdermal Patch Key Raw Materials

        12.2.1 Key Raw Materials

        12.2.2 Raw Materials Key Suppliers

    12.3 Transdermal Patch Production Mode & Process

    12.4 Transdermal Patch Sales and Marketing

        12.4.1 Transdermal Patch Sales Channels

        12.4.2 Transdermal Patch Distributors

    12.5 Transdermal Patch Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    13.1 Transdermal Patch Industry Trends

    13.2 Transdermal Patch Market Drivers

    13.3 Transdermal Patch Market Challenges

    13.4 Transdermal Patch Market Restraints

14 Key Findings in The Global Transdermal Patch Study

15 Appendix

    15.1 Research Methodology

        15.1.1 Methodology/Research Approach

        15.1.2 Data Source

    15.2 Author Details

    15.3 Disclaimer

List of Tables

Table 1. Global Transdermal Patch Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Methyl Salicylate-based Patch

Table 3. Major Manufacturers of Rivastigmine Transdermal Patch

Table 4. Major Manufacturers of Fentanyl Transdermal Patch

Table 5. Major Manufacturers of Lidocaine Patch

Table 6. Major Manufacturers of Diclofenac Patch

Table 7. Major Manufacturers of Nicotine Transdermal Patch

Table 8. Major Manufacturers of Others

Table 9. Global Transdermal Patch Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 10. Global Transdermal Patch Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 11. Global Transdermal Patch Sales by Region (2017-2022) & (M Pcs)

Table 12. Global Transdermal Patch Sales Market Share by Region (2017-2022)

Table 13. Global Transdermal Patch Sales by Region (2023-2028) & (M Pcs)

Table 14. Global Transdermal Patch Sales Market Share by Region (2023-2028)

Table 15. Global Transdermal Patch Revenue by Region (2017-2022) & (US$ Million)

Table 16. Global Transdermal Patch Revenue Market Share by Region (2017-2022)

Table 17. Global Transdermal Patch Revenue by Region (2023-2028) & (US$ Million)

Table 18. Global Transdermal Patch Revenue Market Share by Region (2023-2028)

Table 19. Global Transdermal Patch Sales by Manufacturers (2017-2022) & (M Pcs)

Table 20. Global Transdermal Patch Sales Share by Manufacturers (2017-2022)

Table 21. Global Transdermal Patch Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 22. Global Transdermal Patch Revenue Share by Manufacturers (2017-2022)

Table 23. Transdermal Patch Price by Manufacturers (2017-2022) &(USD/Pc)

Table 24. Global Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transdermal Patch as of 2021)

Table 26. Transdermal Patch Manufacturing Base Distribution and Headquarters

Table 27. Manufacturers Transdermal Patch Product Offered

Table 28. Date of Manufacturers Enter into Transdermal Patch Market

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Transdermal Patch Sales by Type (2017-2022) & (M Pcs)

Table 31. Global Transdermal Patch Sales by Type (2023-2028) & (M Pcs)

Table 32. Global Transdermal Patch Sales Share by Type (2017-2022)

Table 33. Global Transdermal Patch Sales Share by Type (2023-2028)

Table 34. Global Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)

Table 35. Global Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)

Table 36. Global Transdermal Patch Revenue Share by Type (2017-2022)

Table 37. Global Transdermal Patch Revenue Share by Type (2023-2028)

Table 38. Transdermal Patch Price by Type (2017-2022) & (USD/Pc)

Table 39. Global Transdermal Patch Price Forecast by Type (2023-2028) & (USD/Pc)

Table 40. Global Transdermal Patch Sales by Application (2017-2022) & (M Pcs)

Table 41. Global Transdermal Patch Sales by Application (2023-2028) & (M Pcs)

Table 42. Global Transdermal Patch Sales Share by Application (2017-2022)

Table 43. Global Transdermal Patch Sales Share by Application (2023-2028)

Table 44. Global Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)

Table 45. Global Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)

Table 46. Global Transdermal Patch Revenue Share by Application (2017-2022)

Table 47. Global Transdermal Patch Revenue Share by Application (2023-2028)

Table 48. Transdermal Patch Price by Application (2017-2022) & (USD/Pc)

Table 49. Global Transdermal Patch Price Forecast by Application (2023-2028) & (USD/Pc)

Table 50. North America Transdermal Patch Sales by Type (2017-2022) & (M Pcs)

Table 51. North America Transdermal Patch Sales by Type (2023-2028) & (M Pcs)

Table 52. North America Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)

Table 53. North America Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)

Table 54. North America Transdermal Patch Sales by Application (2017-2022) & (M Pcs)

Table 55. North America Transdermal Patch Sales by Application (2023-2028) & (M Pcs)

Table 56. North America Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)

Table 57. North America Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)

Table 58. North America Transdermal Patch Sales by Country (2017-2022) & (M Pcs)

Table 59. North America Transdermal Patch Sales by Country (2023-2028) & (M Pcs)

Table 60. North America Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)

Table 61. North America Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)

Table 62. Europe Transdermal Patch Sales by Type (2017-2022) & (M Pcs)

Table 63. Europe Transdermal Patch Sales by Type (2023-2028) & (M Pcs)

Table 64. Europe Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)

Table 65. Europe Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)

Table 66. Europe Transdermal Patch Sales by Application (2017-2022) & (M Pcs)

Table 67. Europe Transdermal Patch Sales by Application (2023-2028) & (M Pcs)

Table 68. Europe Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)

Table 69. Europe Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)

Table 70. Europe Transdermal Patch Sales by Country (2017-2022) & (M Pcs)

Table 71. Europe Transdermal Patch Sales by Country (2023-2028) & (M Pcs)

Table 72. Europe Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)

Table 73. Europe Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)

Table 74. Asia Pacific Transdermal Patch Sales by Type (2017-2022) & (M Pcs)

Table 75. Asia Pacific Transdermal Patch Sales by Type (2023-2028) & (M Pcs)

Table 76. Asia Pacific Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)

Table 77. Asia Pacific Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)

Table 78. Asia Pacific Transdermal Patch Sales by Application (2017-2022) & (M Pcs)

Table 79. Asia Pacific Transdermal Patch Sales by Application (2023-2028) & (M Pcs)

Table 80. Asia Pacific Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)

Table 81. Asia Pacific Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)

Table 82. Asia Pacific Transdermal Patch Sales by Region (2017-2022) & (M Pcs)

Table 83. Asia Pacific Transdermal Patch Sales by Region (2023-2028) & (M Pcs)

Table 84. Asia Pacific Transdermal Patch Revenue by Region (2017-2022) & (US$ Million)

Table 85. Asia Pacific Transdermal Patch Revenue by Region (2023-2028) & (US$ Million)

Table 86. Latin America Transdermal Patch Sales by Type (2017-2022) & (M Pcs)

Table 87. Latin America Transdermal Patch Sales by Type (2023-2028) & (M Pcs)

Table 88. Latin America Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)

Table 89. Latin America Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)

Table 90. Latin America Transdermal Patch Sales by Application (2017-2022) & (M Pcs)

Table 91. Latin America Transdermal Patch Sales by Application (2023-2028) & (M Pcs)

Table 92. Latin America Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)

Table 93. Latin America Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)

Table 94. Latin America Transdermal Patch Sales by Country (2017-2022) & (M Pcs)

Table 95. Latin America Transdermal Patch Sales by Country (2023-2028) & (M Pcs)

Table 96. Latin America Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)

Table 97. Latin America Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)

Table 98. Middle East and Africa Transdermal Patch Sales by Type (2017-2022) & (M Pcs)

Table 99. Middle East and Africa Transdermal Patch Sales by Type (2023-2028) & (M Pcs)

Table 100. Middle East and Africa Transdermal Patch Revenue by Type (2017-2022) & (US$ Million)

Table 101. Middle East and Africa Transdermal Patch Revenue by Type (2023-2028) & (US$ Million)

Table 102. Middle East and Africa Transdermal Patch Sales by Application (2017-2022) & (M Pcs)

Table 103. Middle East and Africa Transdermal Patch Sales by Application (2023-2028) & (M Pcs)

Table 104. Middle East and Africa Transdermal Patch Revenue by Application (2017-2022) & (US$ Million)

Table 105. Middle East and Africa Transdermal Patch Revenue by Application (2023-2028) & (US$ Million)

Table 106. Middle East and Africa Transdermal Patch Sales by Country (2017-2022) & (M Pcs)

Table 107. Middle East and Africa Transdermal Patch Sales by Country (2023-2028) & (M Pcs)

Table 108. Middle East and Africa Transdermal Patch Revenue by Country (2017-2022) & (US$ Million)

Table 109. Middle East and Africa Transdermal Patch Revenue by Country (2023-2028) & (US$ Million)

Table 110. Hisamitsu Pharmaceutical Corporation Information

Table 111. Hisamitsu Pharmaceutical Description and Major Businesses

Table 112. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 113. Hisamitsu Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Hisamitsu Pharmaceutical Recent Developments

Table 115. Johnson & Johnson Corporation Information

Table 116. Johnson & Johnson Description and Major Businesses

Table 117. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 118. Johnson & Johnson Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. Johnson & Johnson Recent Developments

Table 120. Novartis Corporation Information

Table 121. Novartis Description and Major Businesses

Table 122. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 123. Novartis Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Novartis Recent Developments

Table 125. UCB Pharma Corporation Information

Table 126. UCB Pharma Description and Major Businesses

Table 127. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 128. UCB Pharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. UCB Pharma Recent Developments

Table 130. Mylan Corporation Information

Table 131. Mylan Description and Major Businesses

Table 132. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 133. Mylan Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Mylan Recent Developments

Table 135. Teva Pharmaceutical Corporation Information

Table 136. Teva Pharmaceutical Description and Major Businesses

Table 137. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 138. Teva Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Teva Pharmaceutical Recent Developments

Table 140. Nitto Denko Corporation Information

Table 141. Nitto Denko Description and Major Businesses

Table 142. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 143. Nitto Denko Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Nitto Denko Recent Developments

Table 145. Grünenthal Corporation Information

Table 146. Grünenthal Description and Major Businesses

Table 147. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 148. Grünenthal Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Grünenthal Recent Developments

Table 150. IBSA Group Corporation Information

Table 151. IBSA Group Description and Major Businesses

Table 152. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 153. IBSA Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. IBSA Group Recent Developments

Table 155. GSK Corporation Information

Table 156. GSK Description and Major Businesses

Table 157. GSK Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 158. GSK Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. GSK Recent Developments

Table 160. Luye Pharma Group Corporation Information

Table 161. Luye Pharma Group Description and Major Businesses

Table 162. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 163. Luye Pharma Group Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 164. Luye Pharma Group Recent Developments

Table 165. Pfizer Corporation Information

Table 166. Pfizer Description and Major Businesses

Table 167. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 168. Pfizer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 169. Pfizer Recent Developments

Table 170. Chattem Corporation Information

Table 171. Chattem Description and Major Businesses

Table 172. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 173. Chattem Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 174. Chattem Recent Developments

Table 175. Dr Reddy’s Laboratories Corporation Information

Table 176. Dr Reddy’s Laboratories Description and Major Businesses

Table 177. Dr Reddy’s Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 178. Dr Reddy’s Laboratories Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 179. Dr Reddy’s Laboratories Recent Developments

Table 180. Bayer Corporation Information

Table 181. Bayer Description and Major Businesses

Table 182. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 183. Bayer Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 184. Bayer Recent Developments

Table 185. Mundipharma Corporation Information

Table 186. Mundipharma Description and Major Businesses

Table 187. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 188. Mundipharma Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 189. Mundipharma Recent Developments

Table 190. Endo International Corporation Information

Table 191. Endo International Description and Major Businesses

Table 192. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 193. Endo International Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 194. Endo International Recent Developments

Table 195. Beijing Tide Pharmaceutical Corporation Information

Table 196. Beijing Tide Pharmaceutical Description and Major Businesses

Table 197. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$ Million), Price (USD/Pc) and Gross Margin (2017-2022)

Table 198. Beijing Tide Pharmaceutical Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications

Table 199. Beijing Tide Pharmaceutical Recent Developments

Table 200. Key Raw Materials Lists

Table 201. Raw Materials Key Suppliers Lists

Table 202. Transdermal Patch Distributors List

Table 203. Transdermal Patch Customers List

Table 204. Transdermal Patch Market Trends

Table 205. Transdermal Patch Market Drivers

Table 206. Transdermal Patch Market Challenges

Table 207. Transdermal Patch Market Restraints

Table 208. Research Programs/Design for This Report

Table 209. Key Data Information from Secondary Sources

Table 210. Key Data Information from Primary Sources

List of Figures

Figure 1. Transdermal Patch Product Picture

Figure 3. Global Transdermal Patch Market Share by Type in 2021 & 2028

Figure 3. Methyl Salicylate-based Patch Product Picture

Figure 4. Rivastigmine Transdermal Patch Product Picture

Figure 5. Fentanyl Transdermal Patch Product Picture

Figure 6. Lidocaine Patch Product Picture

Figure 7. Diclofenac Patch Product Picture

Figure 8. Nicotine Transdermal Patch Product Picture

Figure 9. Others Product Picture

Figure 10. Global Transdermal Patch Market Share by Application in 2021 & 2028

Figure 11. Rx Channel

Figure 12. OTC Channel

Figure 13. Transdermal Patch Report Years Considered

Figure 14. Global Transdermal Patch Sales 2017-2028 (M Pcs)

Figure 15. Global Transdermal Patch Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 16. Global Transdermal Patch Revenue 2017-2028 (US$ Million)

Figure 17. Global Transdermal Patch Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 18. Global Transdermal Patch Sales Market Share by Region (2017-2022)

Figure 19. Global Transdermal Patch Sales Market Share by Region (2023-2028)

Figure 20. North America Transdermal Patch Sales YoY (2017-2028) & (M Pcs)

Figure 21. North America Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Europe Transdermal Patch Sales YoY (2017-2028) & (M Pcs)

Figure 23. Europe Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Asia-Pacific Transdermal Patch Sales YoY (2017-2028) & (M Pcs)

Figure 25. Asia-Pacific Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)

Figure 26. Latin America Transdermal Patch Sales YoY (2017-2028) & (M Pcs)

Figure 27. Latin America Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)

Figure 28. Middle East & Africa Transdermal Patch Sales YoY (2017-2028) & (M Pcs)

Figure 29. Middle East & Africa Transdermal Patch Revenue YoY (2017-2028) & (US$ Million)

Figure 30. The Transdermal Patch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 31. The Top 5 and 10 Largest Manufacturers of Transdermal Patch in the World: Market Share by Transdermal Patch Revenue in 2021

Figure 32. Global Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 33. Global Transdermal Patch Sales Market Share by Type (2017-2028)

Figure 34. Global Transdermal Patch Revenue Market Share by Type (2017-2028)

Figure 35. Global Transdermal Patch Sales Market Share by Application (2017-2028)

Figure 36. Global Transdermal Patch Revenue Market Share by Application (2017-2028)

Figure 37. North America Transdermal Patch Sales Market Share by Type (2017-2028)

Figure 38. North America Transdermal Patch Revenue Market Share by Type (2017-2028)

Figure 39. North America Transdermal Patch Sales Market Share by Application (2017-2028)

Figure 40. North America Transdermal Patch Revenue Market Share by Application (2017-2028)

Figure 41. North America Transdermal Patch Sales Share by Country (2017-2028)

Figure 42. North America Transdermal Patch Revenue Share by Country (2017-2028)

Figure 43. U.S. Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 44. Canada Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 45. Europe Transdermal Patch Sales Market Share by Type (2017-2028)

Figure 46. Europe Transdermal Patch Revenue Market Share by Type (2017-2028)

Figure 47. Europe Transdermal Patch Sales Market Share by Application (2017-2028)

Figure 48. Europe Transdermal Patch Revenue Market Share by Application (2017-2028)

Figure 49. Europe Transdermal Patch Sales Share by Country (2017-2028)

Figure 50. Europe Transdermal Patch Revenue Share by Country (2017-2028)

Figure 51. Germany Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 52. France Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 53. U.K. Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 54. Italy Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 55. Russia Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 56. Asia Pacific Transdermal Patch Sales Market Share by Type (2017-2028)

Figure 57. Asia Pacific Transdermal Patch Revenue Market Share by Type (2017-2028)

Figure 58. Asia Pacific Transdermal Patch Sales Market Share by Application (2017-2028)

Figure 59. Asia Pacific Transdermal Patch Revenue Market Share by Application (2017-2028)

Figure 60. Asia Pacific Transdermal Patch Sales Share by Region (2017-2028)

Figure 61. Asia Pacific Transdermal Patch Revenue Share by Region (2017-2028)

Figure 62. China Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 63. Japan Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 64. South Korea Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 65. India Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 66. Australia Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 67. China Taiwan Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 68. Indonesia Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 69. Thailand Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 70. Malaysia Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 71. Latin America Transdermal Patch Sales Market Share by Type (2017-2028)

Figure 72. Latin America Transdermal Patch Revenue Market Share by Type (2017-2028)

Figure 73. Latin America Transdermal Patch Sales Market Share by Application (2017-2028)

Figure 74. Latin America Transdermal Patch Revenue Market Share by Application (2017-2028)

Figure 75. Latin America Transdermal Patch Sales Share by Country (2017-2028)

Figure 76. Latin America Transdermal Patch Revenue Share by Country (2017-2028)

Figure 77. Mexico Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 78. Brazil Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 79. Argentina Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 80. Middle East and Africa Transdermal Patch Sales Market Share by Type (2017-2028)

Figure 81. Middle East and Africa Transdermal Patch Revenue Market Share by Type (2017-2028)

Figure 82. Middle East and Africa Transdermal Patch Sales Market Share by Application (2017-2028)

Figure 83. Middle East and Africa Transdermal Patch Revenue Market Share by Application (2017-2028)

Figure 84. Middle East and Africa Transdermal Patch Sales Share by Country (2017-2028)

Figure 85. Middle East and Africa Transdermal Patch Revenue Share by Country (2017-2028)

Figure 86. Turkey Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 87. Saudi Arabia Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 88. UAE Transdermal Patch Revenue (2017-2028) & (US$ Million)

Figure 89. Transdermal Patch Value Chain

Figure 90. Transdermal Patch Production Process

Figure 91. Channels of Distribution

Figure 92. Distributors Profiles

Figure 93. Bottom-up and Top-down Approaches for This Report

Figure 94. Data Triangulation

Figure 95. Key Executives Interviewed

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Novocure